Long-Term Safety and Disease Control of Ruxolitinib Cream in Children Aged 2 to 6 and 7 to 11 Years: Results From the TRuE-AD3 Study

Authors

Andrea Zaenglein MD

Publication/Presentation Date

2-2025

Volume

155

Issue

2

First Page

191

Last Page

191

Published In/Presented At

https://doi.org/10.1016/j.jaci.2024.12.599

Department(s)

Department of Medicine Faculty

Document Type

Article